Celnalid 25mg Capsule Exporter from India | Bulk Lenalidomide Supply to Washington, London, Bangkok, Canberra, Singapore, & Kingston | Ernest Impex

Celnalid 25mg Capsule: Advanced Immunomodulatory Therapy for Multiple Myeloma and Myelodysplastic Syndromes

Extensive Product Profile: In-Depth Insights on Celnalid 25mg Capsules

Celnalid 25mg Capsule, manufactured under strict global compliance systems by the oncology division of Celon Laboratories Ltd., is a highly effective, maximum standard-strength oral antineoplastic and immunomodulatory treatment. Each capsule contains precisely Lenalidomide ($25text{ mg}$) as its active pharmaceutical ingredient. Lenalidomide is a potent analogue of thalidomide belonging to the chemical class of isoindolones. It is designed to selectively manipulate cellular environments, alter cytokine release, and stimulate defense cells to disrupt blood-based cancers at their core.

1. Clinical Indications & Target Therapeutic Applications

Multiple Myeloma (MM): Used in combination with dexamethasone or as a standalone maintenance therapy following autologous stem cell transplantation (ASCT) for patients with newly diagnosed or relapsed/refractory multiple myeloma. The $25text{ mg}$ strength is typically utilized during the primary induction cycles (e.g., Days 1–21 of a 28-day cycle).

Myelodysplastic Syndromes (MDS): Indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with a specific cytogenetic abnormality—the deletion 5q (del 5q) chromosomal mutation, with or without additional cytogenetic abnormalities.

2. Comprehensive Mechanism of Action (MOA)

Cereblon E3 Ubiquitin Ligase Binding: Lenalidomide binds directly to cereblon (CRBN), a component of the cullin-RING E3 ubiquitin ligase enzyme complex. This binding selectively alters the substrate specificity of the ligase, targeting two essential lymphoid transcription factors—IKZF1 (Ikaros) and IKZF3 (Aiolos)—for rapid cellular degradation.

Direct Tumor Suppression & Apoptosis: The destruction of Ikaros and Aiolos causes a down-regulation of crucial survival factors in B-cell malignancies, leading to immediate cell cycle arrest and programmed cell death (apoptosis) in malignant plasma cells.

3. Storage, Stability, and Handling Protocols

Environmental Matrix: Store Celnalid 25mg Capsules in their original moisture-resistant blister packaging or bottles at controlled room temperature, strictly between 20°C to 25°C (68°F to 77°F). Protect the inventory from high ambient steam, humidity, heat, and direct exposure to light.

Administration Matrix: Capsules must be swallowed completely whole with a glass of water, once daily at the same time, either with or without food. Do not crush, chew, open, or break the capsule shell, as direct contact with the internal powder poses handling risks and alters designated absorption rates.

Potential Side Effects of Celnalid 25mg

Severe Myelosuppression: Significant reductions in blood cell counts, leading to severe neutropenia (low white cells increasing susceptibility to infections), thrombocytopenia (low platelets increasing bruising or bleeding hazards), and anemia (causing extreme fatigue and weakness). Regular Complete Blood Counts (CBC) are required before and during treatment.

Venous and Arterial Thromboembolism: Patients treated with Lenalidomide face a significantly increased risk of deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and stroke. Prophylactic antithrombotic therapy is highly recommended for most patients.

Export Documentation & Global Trade Compliance

Certificate of Analysis (COA): Providing verifiable batch testing confirming the precise $25text{ mg}$ Lenalidomide strength, active capsule dissolution profiles, and chemical purity indices.

Certificate of Origin (COO): Authenticating true manufacturing provenance within registered Indian oncology production lines.

Customs-Compliant Manifesting: Precision shipping manifests, clean packing lists, and commercial invoicing marked with correct global harmonized system (HS) codes for seamless clearance.

PRESCRIPTION MEDICINE IS YES

Disclaimer: This structural product review is prepared strictly for international wholesale distribution networks, and digital optimization indexing. Celnalid 25mg Capsule (Lenalidomide) is a high-potency, restricted prescription oncology medication. It must be prescribed and managed exclusively by qualified medical professionals in a specialized clinical setting. It is highly unsafe for use during pregnancy or breastfeeding due to severe risks of life-threatening birth defects or embryo-fetal death.

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

www.ernestimpex.com

www.ernestvision.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

📲 WhatsApp Link: https://wa.me/919359902383